SCHEMBL9865

SCHEMBL9865

CC(O)CCN(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14396563 1.00
SCHEMBL19617368 1.00
SCHEMBL8382836 0.84 CA12 (0.35)
SCHEMBL8382833 0.84 CA12 (0.55)
SCHEMBL557310 0.82
SCHEMBL22894143 0.82
SCHEMBL7454184 0.80 ALDH1A1 (0.50)
SCHEMBL4590729 0.78 ALDH1A1 (0.55)
Ammonia Solution, Strong SCHEMBL3819671 0.78 ALDH1A1 (0.48)
SCHEMBL10871343 0.78 ALDH1A1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109608632-A A kind of agent on crack resistance of concrete mud sacrifice agent and preparation method thereof 上海三瑞高分子材料股份有限公司 2019-04-12 CN claimed
CN-102107012-B Ultrasound coupling agent PENGFEI SHAO 2012-10-31 CN claimed
CN-102107012-A Ultrasound gel PENGFEI SHAO 2011-06-29 CN claimed
EP-2209381-A1 DIFFERENTIAL EVAPORATION POTENTIATED DISINFECTANT SYSTEM XY, LLC (US) 2010-07-28 EP claimed
WO-2009038672-A1 DIFFERENTIAL EVAPORATION POTENTIATED DISINFECTANT SYSTEM XY, INC. (US) 2009-03-26 WO claimed
US-5959001-A LOW VISCOSITY; MIXTURE CONTAINING PIGMENT, PASTE-MAKING AGENT, AMINE OR SALT, ADDITION HOMO- OR COPOLYMER BAYER AKTIENGESELLSCHAFT (DE) 1999-09-28 US claimed
EP-0808879-A2 Pigment preparations BAYER AG (DE) 1997-11-26 EP claimed
US-4101633-A BY MIXING WITH AMINO ALCOHOLS EXXON RESEARCH & ENGINEERING CO. (US) 1978-07-18 US claimed
JP-61017554-A None JP disclosed
CN-111989321-B KRAS G12C inhibitors 米拉蒂治疗股份有限公司 2024-05-14 CN disclosed
US-20240101553-A1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2024-03-28 US disclosed
CN-114921391-B 4, 5-cyclic 1,2, 4-triazolones 拜耳股份有限公司 2024-01-02 CN disclosed
US-20230373999-A1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2023-11-23 US disclosed
US-20230287021-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING PROTEGO BIOPHARMA, INC. 2023-09-14 US disclosed
EP-0237880-A1 Phospholipid-containing products, their preparation and use A. Nattermann & Cie. GmbH (DE) 1987-09-23 EP disclosed
EP-0191662-A1 Pristinamycine IIB derivatives, their preparation and pharmaceutical compositions containing them RHONE-POULENC SANTE (FR) 1986-08-20 EP disclosed
JP-S6117554-A CARBAMIC ESTER AND ITS PREPARATION NIPPON PAINT CO LTD 1986-01-25 JP disclosed
US-4356333-A REACTING 1,3-BUTADIENE AND WATER IN WATER AND SULFOLANE USING A CATALYST COMPLEX OF PALLADIUM AND A PHENYLPHOSPHINE AND PROMOTERS OF TERTIARY AMINES AND BICARBONATE; EXTRACTION; CIRCULATION KURARAY COMPANY, LIMITED (JP) 1982-10-26 US disclosed
US-4217236-A Process and composition for removing carbon dioxide containing acidic gases from gaseous mixtures EXXON RESEARCH & ENGINEERING CO. (US) 1980-08-12 US disclosed
US-4101633-A BY MIXING WITH AMINO ALCOHOLS EXXON RESEARCH & ENGINEERING CO. (US) 1978-07-18 US disclosed